Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wallis

Showing results (271-280 of 332) with videos related to

Pageof 34
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 16, 1998
Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research CollaborationJ L Johnson, S Nyole, A Okwera, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 1, 1988
Intestinal enzyme profiles in normal and rotavirus-infected miceJ Collins, W G Starkey, T S Wallis, et al.
Frontiers in Pharmacology|August 14, 2025
Statins for polycystic ovary syndrome in varying resource settings: a phenome-wide association study and evidence synthesisLaura A Zahn, Taylor D Budine, Jana K Shirey-Rice, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Inhibition of isoniazid-induced expression of Mycobacterium tuberculosis antigen 85 in sputum: potential surrogate marker in tuberculosis chemotherapy trialsR S Wallis, M Phillips, J L Johnson, et al.
Journal of Medical Microbiology|February 1, 1988
Expression of an antigen in strains of Salmonella typhimurium which reacts with antibodies to cholera toxinG J Clarke, G M Qi, T S Wallis, et al.
The Journal of Infectious Diseases|July 16, 2010
Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteersRobert S Wallis, Wesley M Jakubiec, Vikas Kumar, et al.
Plos One|April 16, 2014
Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosisRobert S Wallis, Rodney Dawson, Sven O Friedrich, et al.
The Lancet. Respiratory Medicine|March 19, 2021
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trialRobert S Wallis, Sibuse Ginindza, Trevor Beattie, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 24, 2007
Assessment of normalization strategies for quantitative RT-PCR using microdissected tissue samplesHeidi S Erickson, Paul S Albert, John W Gillespie, et al.
Nature Medicine|November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Pageof 34

Showing results (271-280 of 332) with videos related to

Sort By:
Pageof 34
American Journal of Respiratory and Critical Care Medicine|December 16, 1998
Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research CollaborationJ L Johnson, S Nyole, A Okwera, et al.
Journal of Pediatric Gastroenterology and Nutrition|March 1, 1988
Intestinal enzyme profiles in normal and rotavirus-infected miceJ Collins, W G Starkey, T S Wallis, et al.
Frontiers in Pharmacology|August 14, 2025
Statins for polycystic ovary syndrome in varying resource settings: a phenome-wide association study and evidence synthesisLaura A Zahn, Taylor D Budine, Jana K Shirey-Rice, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2001
Inhibition of isoniazid-induced expression of Mycobacterium tuberculosis antigen 85 in sputum: potential surrogate marker in tuberculosis chemotherapy trialsR S Wallis, M Phillips, J L Johnson, et al.
Journal of Medical Microbiology|February 1, 1988
Expression of an antigen in strains of Salmonella typhimurium which reacts with antibodies to cholera toxinG J Clarke, G M Qi, T S Wallis, et al.
The Journal of Infectious Diseases|July 16, 2010
Pharmacokinetics and whole-blood bactericidal activity against Mycobacterium tuberculosis of single doses of PNU-100480 in healthy volunteersRobert S Wallis, Wesley M Jakubiec, Vikas Kumar, et al.
Plos One|April 16, 2014
Mycobactericidal activity of sutezolid (PNU-100480) in sputum (EBA) and blood (WBA) of patients with pulmonary tuberculosisRobert S Wallis, Rodney Dawson, Sven O Friedrich, et al.
The Lancet. Respiratory Medicine|March 19, 2021
Adjunctive host-directed therapies for pulmonary tuberculosis: a prospective, open-label, phase 2, randomised controlled trialRobert S Wallis, Sibuse Ginindza, Trevor Beattie, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|July 24, 2007
Assessment of normalization strategies for quantitative RT-PCR using microdissected tissue samplesHeidi S Erickson, Paul S Albert, John W Gillespie, et al.
Nature Medicine|November 16, 2018
Publisher Correction: A patient-level pooled analysis of treatment-shortening regimens for drug-susceptible pulmonary tuberculosisMarjorie Z Imperial, Payam Nahid, Patrick P J Phillips, et al.
Pageof 34